- HIV Travel Restrictions: Where to Find Help Navigating Them
Here are places to look if you need to find out about HIV travel restrictions and testing requirements of countries around the world. For example, a database of all countries is now being maintained in Europe, and made available through the Web in English, German, and French.
- Tipranavir: FDA Advisory Committee Will Meet May 19, Hear Experts, Public Comment
At a one-day public meeting in Gaithersburg, Maryland (near Washington D.C.), the FDA will hear from experts and members of the public on tipranavir, an important new protease inhibitor expected to be approved soon.
- Sculptra Facial Treatment: New Physician Locator
Dermik, the maker of Sculptra (a treatment for facial lipoatrophy, called New-Fill in some countries) has created a database to help patients find physicians in their area who use the product. Our announcement also points to information from the recent Retroviruses conference on preventing the problem in the first place and avoiding the need for the treatment, by switching antiretroviral regimens if lipoatrophy starts to develop.
- FDA AIDS Announcements, First Quarter 2005
Here are the eight announcements from the AIDS list serve of the U.S. Food and Drug Administration, from January through March 2005.
- Uganda Study Found That Death Reduced HIV Prevalence; Did the Public Take Home the Wrong Message?
Uganda has had a remarkable decline in HIV prevalence, and the question of what caused this decline is controversial. An intensive study of the Rakai region of Uganda from 1994 - 2003 found that much of the decreased prevalence resulted from death of people with HIV. But the incidence of new HIV infections was low throughout this study and did not change greatly, suggesting that the real cause of the success was a large reduction in new infections before the study began. The early data presented at the February 2005 Retroviruses conference also showed increasing use of condoms, and some backsliding on reducing the number of sexual partners. But neither change was big enough to greatly affect the incidence of new infections, at least in the aggregate data across the 50 villages studied. In summary, the big reduction in HIV prevalence occurred because of changes that happened before this study, not those measured within it. Therefore the new information does not contradict reduction in the number of sexual partners as a major cause of Uganda's success.
- Virginity Pledge Did Not Prevent Sexually Transmitted Infections
A major U.S. study of sexually transmitted diseases in young people found that virginity pledges were associated with behaviors that would seem to be protective, and yet had no benefit in preventing disease.
- Prison Health Care: New York Times Series Brings Attention
A three-part series and an editorial in The New York Times, the result of a year's investigation, has brought attention to the bad medical care in prisons in the U.S. -- deficiencies that kill prisoners and allow epidemics to spread. The wrong funding arrangements, incentives to make money by reducing care, and the huge growth in the number of prisoners in the U.S. are major causes. We also comment on shortage of social space as a potential root cause of prison and other problems.
ISSN # 1052-4207
Copyright 2005 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.